IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Glenmark appoints head of APIs and North America operations

2:35 AM MST | December 2, 2013 | Deepti Ramesh

Glenmark Pharmaceuticals (Mumbai, India) says it has appointed Philip Gioia as president/North America and global active pharmaceutical ingredients (APIs). Gioia will be based at Mahwah, NJ, and will report to Glenn Saldanha, chairman and managing director of Glenmark. In his role, Gioia will be responsible for the generics and branded business across North America and the sales and marketing activities of the global API business. Gioia has over 25 years experience in the US pharmaceutical industry, both in generics and branded space, Glenmark says. Gioia joins...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa